Reciprocal crosses are set to control for parental/maternal effects. Generation 1: l(2)*/CyO virgin females x Df(2)X/CyO males (and the reciprocal). Each cross is set in >=8 replicate vials (10 females x 5 males per vial) to reach n>800 scored adults. Vials are randomized in incubator position and rotated daily. Scoring of eclosed adults by wing/marker phenotype is performed blinded to vial identity. A wild-type complementing line and a known allelic non-complementing line are run as concurrent controls.
BSL-1 / arthropod containment. Drosophila are non-hazardous; follow institutional escape-prevention (freeze or ethanol-morgue all flies before disposal, never release). CO2 anesthesia: ensure adequate ventilation; CO2 is an asphyxiant in confined spaces. Propionic acid and Tegosept in food are mild irritants — avoid inhalation of concentrates. Ethanol morgue is flammable — keep away from open flame. Autoclave or freeze used vials before discarding.
Positive control (non-complementation reference): a known allele of the same gene crossed to the deficiency, expected to lack the trans-heterozygous straight-winged class. Negative control (complementation reference): wild-type chromosome 2 over the deficiency, expected to yield the straight-winged class at Mendelian frequency. Internal genetic control: the CyO-balanced sibling class is present in every vial as an internal viability/marker control, confirming the cross worked even when the test class is absent. Reciprocal crosses control for maternal/X-linked confounds.
Under complementation, straight-winged adults should appear at ~1/3 of total viable progeny (since the lethal class among balancer combinations is absent), with hundreds of each class across vials. Under non-complementation, the straight-winged trans-heterozygous class should be essentially absent (<2-3% from rare recombinants/escapers) while the Curly class persists. The wild-type negative control must yield the expected straight-winged frequency; the known-allele positive control must lack it, validating the assay window.
To localize a recessive lethal mutation to a defined chromosomal interval by classical complementation testing in Drosophila using CyO balancer chromosomes, with the absence vs presence of the trans-heterozygous adult class as a marker-tracked, Mendelian-ratio-scored complement/non-complement readout.
Independent: genotype combination of the cross (l(2)*/Df test vs allele/Df positive vs WT/Df negative) and cross direction (reciprocal). Dependent: number and ratio of trans-heterozygous (straight-winged) to balancer (Curly) adult progeny per vial; the binary complement/non-complement call. Controlled: temperature (25 C), humidity (60%), parental density (10 females x 5 males), food batch, vial position (randomized), and scorer blinding.
If mutation l(2) lies within the deficiency Df(2)X interval, the trans-heterozygous l(2)/Df class will be absent (lethal, non-complementation), causing the curly-winged (CyO-balanced) survivor class to dominate; if l(2)* lies outside the interval, trans-heterozygous adults will eclose at the expected ~1/3 of viable progeny (complementation).
Counts per phenotypic class are summed across replicate vials within each cross. Observed straight-winged:Curly ratios are compared to the Mendelian expectation derived from the cross scheme (accounting for CyO/CyO homozygous lethality). The complementation call is made on whether the trans-heterozygous class falls within the complementing expectation or is significantly depleted. Per-vial ratios are plotted to visualize consistency and detect outlier vials (e.g., crowding, contamination).
A chi-square goodness-of-fit test compares observed class counts to expected Mendelian ratios within each cross (alpha = 0.05). Test vs control crosses are compared with a chi-square test of homogeneity or Fisher's exact test on the straight-winged class proportion, with Bonferroni correction across the multiple cross comparisons. With n>800 scored adults, the design detects depletion of the trans-heterozygous class from ~33% to <5% with power >99%. Per-vial variance is examined to confirm no single vial drives the result.